Cargando…

Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain

Detalles Bibliográficos
Autores principales:	Xiao, Sa, Nayak, Baibaswata, Samuel, Arthur, Paldurai, Anandan, Kanabagattebasavarajappa, Mallikarjuna, Prajitno, Teguh Y., Bharoto, Eny E., Collins, Peter L., Samal, Siba K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920174/ https://www.ncbi.nlm.nih.gov/pubmed/35286363 http://dx.doi.org/10.1371/journal.pone.0265578

Ejemplares similares

Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain
por: Xiao, Sa, et al.
Publicado: (2012)

Complete Genome Sequence of a Highly Virulent Newcastle Disease Virus Currently Circulating in Mexico
por: Xiao, Sa, et al.
Publicado: (2013)

Effects of Naturally Occurring Six- and Twelve-Nucleotide Inserts on Newcastle Disease Virus Replication and Pathogenesis
por: Paldurai, Anandan, et al.
Publicado: (2014)

Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
por: Kim, Shin-Hee, et al.
Publicado: (2013)

Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens
por: Kim, Shin-Hee, et al.
Publicado: (2014)

Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2017)

Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006
por: Mohamed, Mahmoud HA, et al.
Publicado: (2011)

Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques
por: Khattar, Sunil K., et al.
Publicado: (2013)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

Complete Genome Sequence of an Avian Paramyxovirus Type 4 from North America Reveals a Shorter Genome and New Genotype
por: Parthiban, Manoharan, et al.
Publicado: (2013)

Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt
por: Abozeid, Hassanein H., et al.
Publicado: (2019)

Complete Genome Sequence of Avian Paramyxovirus (APMV) Serotype 5 Completes the Analysis of Nine APMV Serotypes and Reveals the Longest APMV Genome
por: Samuel, Arthur S., et al.
Publicado: (2010)

Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens
por: Shirvani, Edris, et al.
Publicado: (2020)

A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
por: Shirvani, Edris, et al.
Publicado: (2020)

Author Correction: A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
por: Shirvani, Edris, et al.
Publicado: (2020)

Role of fusion protein cleavage site in the virulence of Newcastle disease virus
por: Panda, Aruna, et al.
Publicado: (2004)

Molecular characterization and complete genome sequence of avian paramyxovirus type 4 prototype strain duck/Hong Kong/D3/75
por: Nayak, Baibaswata, et al.
Publicado: (2008)

Immunization of Chickens with Newcastle Disease Virus Expressing H5 Hemagglutinin Protects against Highly Pathogenic H5N1 Avian Influenza Viruses
por: Nayak, Baibaswata, et al.
Publicado: (2009)

Experimental avian paramyxovirus serotype-3 infection in chickens and turkeys
por: Kumar, Sachin, et al.
Publicado: (2010)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019)

Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs
por: Yoshida, Asuka, et al.
Publicado: (2019)

Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
por: Shirvani, Edris, et al.
Publicado: (2020)

Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2016)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1
por: Khattar, Sunil K., et al.
Publicado: (2010)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
por: DiNapoli, Joshua M., et al.
Publicado: (2010)

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
por: DiNapoli, Joshua M., et al.
Publicado: (2009)

Comparative Protective Efficacies of Novel Avian Paramyxovirus-Vectored Vaccines against Virulent Infectious Bronchitis Virus in Chickens
por: Shirvani, Edris, et al.
Publicado: (2020)

Reverse Genetics of Newcastle Disease Virus
por: Cardenas-Garcia, Stivalis, et al.
Publicado: (2017)

Co-expression of the Hemagglutinin and Neuraminidase by Heterologous Newcastle Disease Virus Vectors Protected Chickens against H5 Clade 2.3.4.4 HPAI Viruses
por: Cho, Yeonwoo, et al.
Publicado: (2018)

Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens
por: Dey, Sohini, et al.
Publicado: (2017)

The Development of Novel Reverse Transcription Loop-Mediated Isothermal Amplification Assays for the Detection and Differentiation of Virulent Newcastle Disease Virus
por: Song, Hye-Soon, et al.
Publicado: (2023)

Antigenic and Molecular Characterization of Virulent Newcastle Disease Viruses Circulating in Ethiopia Between 1976 and 2008
por: Bari, Fufa D, et al.
Publicado: (2021)

Antigenic Variation of Clade 2.1 H5N1 Virus Is Determined by a Few Amino Acid Substitutions Immediately Adjacent to the Receptor Binding Site
por: Koel, Björn F., et al.
Publicado: (2014)

Correction for Koel et al., Antigenic Variation of Clade 2.1 H5N1 Virus Is Determined by a Few Amino Acid Substitutions Immediately Adjacent to the Receptor Binding Site
por: Koel, Björn F., et al.
Publicado: (2014)

Virulence of newcastle disease virus: what is known so far?
por: Dortmans, Jos CFM, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_63t5e9ff6ophf45t5g3hrlvuoh